Abeta toxicity Part 2
Main Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
London
Henry Stewart Talks
2011, 2011
|
Series: | Alzheimer's disease : neurobiology, pathology and treatment
|
Subjects: | |
Online Access: | |
Collection: | Henry Stewart Talks - Collection details see MPG.ReNa |
Table of Contents:
- The Australian imaging, biomarkers and lifestyle (aibl) flagship study of ageing
- Methodology: key outcomes
- Abeta and amyloid imaging
- The progression of AD
- Abeta and memory
- Prediction of conversion from HC to MCI/AD
- Impact of amyloid imaging in MCI patient selection for anti-amyloid therapeutic trials
- Longitudinal PiB PET follow-up
- Plasma Abeta 42 levels in the PiB-PET AIBL subset
- Relation between Abeta oligomers in blood cellular elements, cognition and PiB SUVR
- Plasma ApoE (total) levels: the AIBL study
- Biomarker discovery
- Abeta deposition